CClinicalTrials.gg
CompletedNCT01677416Updated Sep 3, 2012

Joint Ultrasound Evaluation of Asymptomatic Rheumatic Feet

An observational study in Rheumatoid Arthritis, sponsored by Federal University of São Paulo. Completed at 1 site in Brazil. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2012-09-03.

Sponsored by Federal University of São Paulo · Observational

Study type
Observational
Time perspective
Cross-sectional
Enrollment
100
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Objectives: The aims of the present study were to compare ultrasound on asymptomatic feet of patients with rheumatoid arthritis (RA) and normal controls, determine the association between ultrasound and global disease activity, function and goniometric measures in patients with RA and determine the correlation between ultrasound and radiography in the detection of bone erosion.

Methods: The foot joints (talocrural, talocalcaneal, talonavicular, naviculocuneiform, calcaneocuboid, 5th tarsometatarsal and 1st to 5th metatarsophalangeal [MTP] joints) of 50 healthy subjects and 50 patients with RA (all with asymptomatic feet) were evaluated bilaterally regarding quantitative/semi-quantitative synovitis, semi-quantitative Power Doppler (PD) signals and erosion using ultrasound. Statistical significance was set to 5%.

02

Conditions studied

  • Rheumatoid Arthritis

Keywords

  • Rheumatoid arthritis
  • Ultrasonography
  • Synovitis
  • Foot joints
03

In context

Arthritis

3,554 studies on the registry are indexed under Arthritis; 317 are open to participants now.

This study's enrollment of 100 is below the median of 155 across 1,057 observational studies indexed under Arthritis.

Browse Arthritis studies →

Lead sponsor

Federal University of São Paulo is the lead sponsor of 427 studies on the registry; 22 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Rheumatoid Arthritis

Inclusion criteria

Rheumatoid Arthritis Group:

  • RA with at least one year since diagnosis
  • Asymptomatic feet
  • Age between 18 and 65 years Control group
  • absence of known osteoarticular disease

Exclusion criteria

Exclusion Criteria for both groups:

  • Peripheral venous insufficiency with retrograde venous flow and/or ochre dermatitis
  • Previous surgical intervention and/or fracture in feet/ankles
  • Intra-articular corticosteroid injection in previous three months in any of the joints evaluated
  • Foot neuropathy
  • Pain and swelling in feet or ankles
05

Study design

Time perspective
Cross-sectional
Enrollment
100 participants (actual)

Groups and cohorts

  • Rheumatoid Arthritis Group

    RA with at least one year since diagnosis, asymptomatic feet, and age between 18 and 65 years

  • Control group

    Absence of known osteoarticular disease

06

What researchers measure

Primary outcomes

  1. Presence of synovial effusion and/or synovial hypertrophy

    Ultrasound evaluation - quantitative measurement considered the distance between the joint capsule and subchondral bone of the joints studied (talocrural, talocalcaneal (medial, lateral and posterior windows); dorsal face of calcaneocuboid, talonavicular, medial naviculocuneiform, 5th tarsometatarsal and metatarsophalangeal (MTP) (dorsal and volar faces of 1st to 5th MTP joints and lateral face of 1st and 5th MTP joints). A modified score was used for the semi-quantitative measurement, ranging from 0 to 3: 0-no synovial thickening; 1-minimal synovial thickening in joint recess; 2-synovial thickening in entire joint recess causing bulging of joint capsule; and 3-synovial thickening in joint recess with bulging of joint capsule and extending to at least one bone diaphysis. "Presence of synovitis" was defined as synovial hypertrophy of at least Grade 1 in the semi-quantitative analysis (gray scale - ultrasound)

    Time frame: Baseline

  2. Presence of bone erosion

    defined based on the preliminary OMERACT criteria: intra-articular discontinuity of the bone surface observed on two perpendicular planes. A previously established semi-quantitative score (0-3) was employed: 0-uniform bone surface; 1-irregular bone surface; 2-bone surface defect on two planes; 3-bone defect causing extensive bone destruction. The "presence of erosion" was defined as the presence of at least Grade 2 erosion.

    Time frame: Baseline

Secondary outcomes

  1. Radiographic evaluation

    A blinded radiologist analysed the presence of erosion in each joint studied. For such, ankle (AP and profile) and foot (AP and profile with load) radiographs were taken.

    Time frame: Baseline

  2. Intraobserver and interobserver agreement

    The patients with RA were submitted to clinical and ultrasound evaluations of the feet and ankles on the same day. The ultrasound measurements intraobserver/interobserver agreement was performed on the talocrural, talonavicular and 5th MTP joints, using 20% of the sample. For this, the ultrasound exams were performed by another rheumatologist.

    Time frame: Baseline

  3. Presence of synovial blood flow

    The presence of Power Doppler (PD) signals was evaluated in the bone margins, joint spaces, and peri-articular tissues (frequency of 8 MHz and pulse repetition rate of 750 MHz). A semi-quantitative score (0-3) was employed\[14\]: 0-no signal; 1-minimal signal, presence of simple vessels; 2-moderate signal, presence of confluent vessels with signal in less than 50% of the area evaluated; 3-intense signal (more than 50% of area evaluated). "Active synovitis" or "presence of PD signal" was defined as the presence of intra-articular synovitis with a positive PD signal (at least Grade 1).

    Time frame: Baseline

07

Study locations

1 site
  • Universidade Federal de Sao Paulo
    Sao Paulo, SP - Sao Paulo 04023-062, Brazil
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 3, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01677416
Lead sponsor
Federal University of São Paulo
Responsible party
Anamaria Jones (Principal Investigator, Federal University of São Paulo) — Principal investigator
First posted
Sep 3, 2012
Start date
Mar 2011
Primary completion
Mar 2012
Completion
Mar 2012
Last update
Sep 3, 2012

Study contacts

Rita Furtado, MD
principal investigator · Federal University of São Paulo

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion